Fuji has issued revised manual reprocessing instructions for its ED-530XT duodenoscope to replace those provided in the original device labeling, the Food and Drug Administration reports. Health care facilities using the duodenoscope should train staff on the new validated instructions and implement them as soon as possible, the agency said. FDA also encourages facilities to apply the revised reprocessing instructions to Fuji’s 250 and 450 duodenoscope models. “While formal validation testing with the revised reprocessing instructions is ongoing for Fuji’s 250 and 450 duodenoscope models, FDA…believes that the revised reprocessing instructions for the ED-530XT duodenoscope are more robust because of additional pre-cleaning, cleaning and high-level disinfection steps and, for that reason, should increase the safety margin of the 250 and 450 duodenoscope models,” the agency said.

Related News Articles

Headline
The National Collaborative for Improving the Clinical Learning Environment this week released guidance to help health care system leaders work with clinical…
Headline
The Centers for Medicare & Medicaid Services should continue to work with national standards body X12 to include the new unique device identifier on its…
Headline
The Centers for Disease Control and Prevention today issued recommendations to help health care providers and laboratories prevent the spread of Candida auris…
Headline
The AHA today urged the Centers for Medicare & Medicaid Services not to finalize in the calendar year 2018 final rule its proposal to redesign the home…
Headline
Inpatient rehabilitation facilities and long-term care hospitals have until Sept. 30 to review their 2016 quality data before it is publicly reported on the…
Headline
The Institute for Safe Medication Practices yesterday released a tool to help hospitals and outpatient facilities evaluate their safety practices for “…